Cargando…

Clinical Features and Prognoses of IgG4-Positive and IgG4-Negative Lacrimal Lymphomas

Purpose: The clinical characteristics and prognoses of immunoglobulin G4-positive (IgG4+) and IgG4-negative (IgG4−) lacrimal lymphomas were comparatively analyzed to screen for clinical indicators with differential diagnostic significance. Methods: This was a retrospective and single-center clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Rui, Wang, Jinjin, Wang, Nan, Li, Jing, Ge, Xin, Zhang, Jingxue, Ma, Jianmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982601/
https://www.ncbi.nlm.nih.gov/pubmed/33763358
http://dx.doi.org/10.3389/fonc.2021.622847
_version_ 1783667754474143744
author Liu, Rui
Wang, Jinjin
Wang, Nan
Li, Jing
Ge, Xin
Zhang, Jingxue
Ma, Jianmin
author_facet Liu, Rui
Wang, Jinjin
Wang, Nan
Li, Jing
Ge, Xin
Zhang, Jingxue
Ma, Jianmin
author_sort Liu, Rui
collection PubMed
description Purpose: The clinical characteristics and prognoses of immunoglobulin G4-positive (IgG4+) and IgG4-negative (IgG4−) lacrimal lymphomas were comparatively analyzed to screen for clinical indicators with differential diagnostic significance. Methods: This was a retrospective and single-center clinical study. From June 2011 to June 2018, clinical data of 39 patients with lacrimal lymphoma, diagnosed by histopathology were collected from the Department of Ophthalmology, Beijing Tongren Hospital, Capital Medical University. Results: According to inclusion and exclusion criteria, 30 (76.9%) were in the IgG4− group and 9 (23.1%) were in the IgG4+ group. In the IgG4+ group, the sex ratio of male to female was 2:1 and the mean age was 56.67 ± 13.29 years old. In the IgG4− group, the sex ratio of male to female was 3.29:1 and the mean age was 61.47 ± 12.87 years old. Statistical analysis of the clinical indicators showed significant differences between the two groups in affected eye, preoperative history of glucocorticoids, ocular nerve thickening, the expression of serum IgG4 and prognosis (P < 0.05). There was no significant statistical difference in laboratory indicators between the two groups, including C3, C4, RF, ASO, CRP, IgA, IgM, IgG, IgG1, IgG2, and IgG3 (P > 0.05). The event-free cumulative percentages at 3 and 5 years for the 39 lacrimal lymphomas were 81.1 and 62.4%, respectively, with recurrence and death as end events. In 34 lacrimal gland MALT lymphoma cases, the event-free cumulative percentages at 3 and 5 years were 84.4 and 69.1%, respectively. In the IgG4+ and IgG4− groups, the event-free cumulative percentages at 3 years were 75.0 and 87.7%, respectively. The event-free cumulative percentage at 5 years was 62.6% in the IgG4-group and insignificant in the IgG4+ group. There was no statistical difference in event-free cumulative percentage between the two groups (P = 0.983). Conclusion: The pathogenesis and disease characteristics of IgG4-positive lacrimal lymphoma may differ from IgG4-negative lacrimal lymphoma, but the positive expression of IgG4 may not have significant influence on the recurrence of lacrimal lymphoma.
format Online
Article
Text
id pubmed-7982601
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79826012021-03-23 Clinical Features and Prognoses of IgG4-Positive and IgG4-Negative Lacrimal Lymphomas Liu, Rui Wang, Jinjin Wang, Nan Li, Jing Ge, Xin Zhang, Jingxue Ma, Jianmin Front Oncol Oncology Purpose: The clinical characteristics and prognoses of immunoglobulin G4-positive (IgG4+) and IgG4-negative (IgG4−) lacrimal lymphomas were comparatively analyzed to screen for clinical indicators with differential diagnostic significance. Methods: This was a retrospective and single-center clinical study. From June 2011 to June 2018, clinical data of 39 patients with lacrimal lymphoma, diagnosed by histopathology were collected from the Department of Ophthalmology, Beijing Tongren Hospital, Capital Medical University. Results: According to inclusion and exclusion criteria, 30 (76.9%) were in the IgG4− group and 9 (23.1%) were in the IgG4+ group. In the IgG4+ group, the sex ratio of male to female was 2:1 and the mean age was 56.67 ± 13.29 years old. In the IgG4− group, the sex ratio of male to female was 3.29:1 and the mean age was 61.47 ± 12.87 years old. Statistical analysis of the clinical indicators showed significant differences between the two groups in affected eye, preoperative history of glucocorticoids, ocular nerve thickening, the expression of serum IgG4 and prognosis (P < 0.05). There was no significant statistical difference in laboratory indicators between the two groups, including C3, C4, RF, ASO, CRP, IgA, IgM, IgG, IgG1, IgG2, and IgG3 (P > 0.05). The event-free cumulative percentages at 3 and 5 years for the 39 lacrimal lymphomas were 81.1 and 62.4%, respectively, with recurrence and death as end events. In 34 lacrimal gland MALT lymphoma cases, the event-free cumulative percentages at 3 and 5 years were 84.4 and 69.1%, respectively. In the IgG4+ and IgG4− groups, the event-free cumulative percentages at 3 years were 75.0 and 87.7%, respectively. The event-free cumulative percentage at 5 years was 62.6% in the IgG4-group and insignificant in the IgG4+ group. There was no statistical difference in event-free cumulative percentage between the two groups (P = 0.983). Conclusion: The pathogenesis and disease characteristics of IgG4-positive lacrimal lymphoma may differ from IgG4-negative lacrimal lymphoma, but the positive expression of IgG4 may not have significant influence on the recurrence of lacrimal lymphoma. Frontiers Media S.A. 2021-03-08 /pmc/articles/PMC7982601/ /pubmed/33763358 http://dx.doi.org/10.3389/fonc.2021.622847 Text en Copyright © 2021 Liu, Wang, Wang, Li, Ge, Zhang and Ma. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Liu, Rui
Wang, Jinjin
Wang, Nan
Li, Jing
Ge, Xin
Zhang, Jingxue
Ma, Jianmin
Clinical Features and Prognoses of IgG4-Positive and IgG4-Negative Lacrimal Lymphomas
title Clinical Features and Prognoses of IgG4-Positive and IgG4-Negative Lacrimal Lymphomas
title_full Clinical Features and Prognoses of IgG4-Positive and IgG4-Negative Lacrimal Lymphomas
title_fullStr Clinical Features and Prognoses of IgG4-Positive and IgG4-Negative Lacrimal Lymphomas
title_full_unstemmed Clinical Features and Prognoses of IgG4-Positive and IgG4-Negative Lacrimal Lymphomas
title_short Clinical Features and Prognoses of IgG4-Positive and IgG4-Negative Lacrimal Lymphomas
title_sort clinical features and prognoses of igg4-positive and igg4-negative lacrimal lymphomas
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982601/
https://www.ncbi.nlm.nih.gov/pubmed/33763358
http://dx.doi.org/10.3389/fonc.2021.622847
work_keys_str_mv AT liurui clinicalfeaturesandprognosesofigg4positiveandigg4negativelacrimallymphomas
AT wangjinjin clinicalfeaturesandprognosesofigg4positiveandigg4negativelacrimallymphomas
AT wangnan clinicalfeaturesandprognosesofigg4positiveandigg4negativelacrimallymphomas
AT lijing clinicalfeaturesandprognosesofigg4positiveandigg4negativelacrimallymphomas
AT gexin clinicalfeaturesandprognosesofigg4positiveandigg4negativelacrimallymphomas
AT zhangjingxue clinicalfeaturesandprognosesofigg4positiveandigg4negativelacrimallymphomas
AT majianmin clinicalfeaturesandprognosesofigg4positiveandigg4negativelacrimallymphomas